Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome

Area of Science:

• Microbiology
• Immunology
• Pathogenesis

Background:

• Sepsis is a major global health threat, often linked to Gram-negative bacterial infections.
• The precise mechanisms driving Gram-negative bacterial sepsis remain incompletely understood.
• Outer membrane vesicles (OMVs) are nanoparticles released by Gram-negative bacteria.

Purpose of the Study:

• To investigate the role of Gram-negative bacterial outer membrane vesicles (OMVs) in sepsis pathogenesis.
• To determine if OMVs can induce a sepsis-like condition in a preclinical model.

Main Methods:

• Intraperitoneal injection of OMVs derived from intestinal Escherichia coli into a mouse model.
• Observation and documentation of host physiological and immunological responses.

Main Results:

• OMV administration resulted in significant lethality in the mouse model.
• OMVs triggered a sepsis-like syndrome, including piloerection, hypothermia, leukopenia, hypotension, and organ dysfunction.
• Systemic inflammation markers, such as tumor necrosis factor-alpha and interleukin-6, were significantly induced.

Conclusions:

• Outer membrane vesicles (OMVs) represent a previously unrecognized microbial factor contributing to sepsis development.
• OMVs are potent inducers of a sepsis-like state, highlighting their pathogenic potential.
• Targeting OMVs could offer a novel therapeutic strategy for preventing or treating Gram-negative bacterial sepsis.